Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (248)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mutation
21
2022
1331
1.640
 Why?
Multiple Myeloma
38
2023
3013
1.630
 Why?
High-Throughput Nucleotide Sequencing
5
2021
178
0.960
 Why?
Translocation, Genetic
14
2021
266
0.930
 Why?
Oncogenes
2
2018
61
0.690
 Why?
Biliary Tract Neoplasms
1
2018
5
0.560
 Why?
Cholangiocarcinoma
1
2018
27
0.550
 Why?
Gene Expression Profiling
14
2022
1099
0.550
 Why?
Genomics
8
2022
266
0.520
 Why?
Proto-Oncogene Proteins B-raf
3
2022
75
0.500
 Why?
Gene Expression Regulation, Neoplastic
10
2022
853
0.460
 Why?
Prognosis
15
2021
2100
0.400
 Why?
Brain Neoplasms
3
2023
302
0.370
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
1020
0.370
 Why?
Gene Dosage
5
2020
73
0.370
 Why?
Genetic Predisposition to Disease
5
2018
525
0.360
 Why?
Plasma Cells
4
2021
233
0.350
 Why?
Genome, Human
4
2021
121
0.340
 Why?
Evolution, Molecular
2
2021
98
0.330
 Why?
Liver Neoplasms
3
2022
341
0.330
 Why?
DNA Mutational Analysis
7
2020
179
0.320
 Why?
Humans
50
2023
52441
0.320
 Why?
Thalidomide
5
2019
376
0.310
 Why?
DNA Copy Number Variations
4
2021
116
0.310
 Why?
In Situ Hybridization, Fluorescence
11
2023
262
0.300
 Why?
Software
2
2021
281
0.280
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
123
0.280
 Why?
Neoplasm Recurrence, Local
3
2021
639
0.270
 Why?
Chromosome Aberrations
6
2022
295
0.260
 Why?
Carcinoma, Hepatocellular
2
2022
208
0.260
 Why?
Polymorphism, Single Nucleotide
3
2018
506
0.250
 Why?
Epigenesis, Genetic
4
2018
396
0.240
 Why?
Clonal Evolution
2
2019
57
0.240
 Why?
Chromosomes, Human, Pair 1
2
2019
95
0.230
 Why?
Immunoglobulin Heavy Chains
3
2014
45
0.230
 Why?
Neoplasm Proteins
3
2017
328
0.230
 Why?
Disease Progression
8
2021
870
0.220
 Why?
Gene Regulatory Networks
2
2022
112
0.210
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
24
0.200
 Why?
Polycomb Repressive Complex 2
2
2021
47
0.200
 Why?
Chromosomes, Human, Pair 14
5
2014
76
0.200
 Why?
Central Nervous System Neoplasms
1
2023
69
0.190
 Why?
Exome
4
2017
53
0.190
 Why?
Hematologic Neoplasms
1
2023
101
0.180
 Why?
Male
24
2021
26874
0.180
 Why?
Female
25
2021
28277
0.180
 Why?
Genome-Wide Association Study
3
2018
184
0.180
 Why?
Middle Aged
17
2021
13133
0.180
 Why?
Aged
15
2021
10242
0.180
 Why?
Japan
2
2018
40
0.170
 Why?
Gene Frequency
2
2017
97
0.170
 Why?
Aged, 80 and over
9
2021
3449
0.160
 Why?
Cell Cycle
1
2021
236
0.160
 Why?
Neoplasms
2
2020
1314
0.160
 Why?
DNA Methylation
3
2016
573
0.160
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
 Why?
Leukemia, Plasma Cell
1
2020
33
0.160
 Why?
Ecosystem
1
2021
99
0.160
 Why?
Chromosomal Instability
1
2019
16
0.160
 Why?
Genes, myc
1
2019
39
0.150
 Why?
Chromosomes, Human, Pair 4
3
2014
30
0.150
 Why?
Diploidy
2
2017
25
0.150
 Why?
Cell Survival
2
2018
598
0.150
 Why?
Chromosomes, Human, Pair 11
3
2014
56
0.150
 Why?
INDEL Mutation
1
2018
4
0.140
 Why?
Genes, Tumor Suppressor
2
2021
73
0.140
 Why?
Mutagenesis
1
2018
58
0.140
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
13
0.140
 Why?
Italy
1
2018
27
0.140
 Why?
Germ-Line Mutation
1
2018
62
0.140
 Why?
Transcriptional Elongation Factors
1
2017
17
0.140
 Why?
Histone-Lysine N-Methyltransferase
2
2016
56
0.140
 Why?
Chromosomes, Human, Pair 5
1
2017
17
0.140
 Why?
Enhancer Elements, Genetic
1
2017
60
0.130
 Why?
Melanoma
1
2020
272
0.130
 Why?
Reproducibility of Results
1
2021
1223
0.130
 Why?
Chromosomes, Human
1
2017
41
0.130
 Why?
Hepatocytes
1
2018
184
0.130
 Why?
Immunologic Factors
1
2017
114
0.130
 Why?
B-Lymphocytes
2
2016
178
0.120
 Why?
Adult
12
2021
14205
0.120
 Why?
Neoplasms, Multiple Primary
1
2016
44
0.120
 Why?
Neoplasm Metastasis
1
2016
235
0.120
 Why?
Melphalan
2
2013
176
0.120
 Why?
Oligodendroglioma
1
2015
7
0.120
 Why?
Endoribonucleases
1
2015
16
0.120
 Why?
Sequence Analysis, DNA
2
2016
220
0.120
 Why?
ras Proteins
1
2015
62
0.120
 Why?
Skin Neoplasms
1
2020
496
0.110
 Why?
Survival Rate
4
2020
944
0.110
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
42
0.110
 Why?
Survival Analysis
5
2015
656
0.110
 Why?
Endoplasmic Reticulum Stress
1
2015
51
0.110
 Why?
SMN Complex Proteins
1
2014
4
0.110
 Why?
Signal Transduction
5
2022
1724
0.110
 Why?
RNA Processing, Post-Transcriptional
1
2014
23
0.110
 Why?
Mutation Rate
3
2021
36
0.110
 Why?
Chromosome Deletion
2
2011
138
0.110
 Why?
Transcription Factors
2
2015
570
0.110
 Why?
Cyclin D
1
2013
18
0.110
 Why?
Kaplan-Meier Estimate
4
2018
485
0.110
 Why?
Genes, erbB-1
1
2013
9
0.100
 Why?
Cell Line, Tumor
4
2022
1429
0.100
 Why?
RNA, Neoplasm
1
2013
45
0.100
 Why?
Nerve Tissue Proteins
1
2015
201
0.100
 Why?
Chromosome Breakage
1
2013
16
0.100
 Why?
Repressor Proteins
1
2014
150
0.100
 Why?
Precursor Cells, B-Lymphoid
1
2013
8
0.100
 Why?
Germinal Center
1
2013
30
0.100
 Why?
RNA Splicing
3
2021
43
0.100
 Why?
Transcriptome
3
2020
357
0.100
 Why?
DNA-Binding Proteins
1
2015
423
0.090
 Why?
Genetic Heterogeneity
1
2012
20
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
187
0.090
 Why?
Acetyltransferases
1
2011
18
0.090
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
26
0.090
 Why?
Antineoplastic Agents
3
2018
1216
0.090
 Why?
Chromosomes, Human, Pair 17
1
2011
35
0.090
 Why?
RNA, Messenger
1
2015
1134
0.090
 Why?
Cell Proliferation
3
2022
1013
0.090
 Why?
DNA, Neoplasm
3
2018
146
0.090
 Why?
Multivariate Analysis
3
2021
601
0.080
 Why?
TOR Serine-Threonine Kinases
1
2010
83
0.080
 Why?
Remission Induction
2
2021
218
0.080
 Why?
Phenotype
3
2022
792
0.080
 Why?
Tumor Suppressor Protein p53
1
2011
224
0.080
 Why?
Clone Cells
2
2021
76
0.080
 Why?
MicroRNAs
1
2013
392
0.080
 Why?
DNA
1
2012
544
0.070
 Why?
Alleles
2
2021
279
0.070
 Why?
Transcriptional Activation
2
2021
127
0.070
 Why?
Spliceosomes
2
2021
10
0.070
 Why?
Follow-Up Studies
3
2020
2294
0.070
 Why?
Genomic Instability
2
2018
87
0.060
 Why?
Epigenomics
2
2017
75
0.060
 Why?
Risk Factors
3
2021
3971
0.060
 Why?
Loss of Heterozygosity
2
2018
78
0.060
 Why?
Disease-Free Survival
2
2019
461
0.060
 Why?
Treatment Outcome
4
2019
5508
0.060
 Why?
Chromosomes, Human, Pair 20
2
2014
10
0.050
 Why?
Protein Binding
2
2017
673
0.050
 Why?
Liver
2
2022
1150
0.050
 Why?
Genotype
2
2017
563
0.050
 Why?
Dexamethasone
2
2019
434
0.050
 Why?
Histones
2
2016
315
0.050
 Why?
Proportional Hazards Models
2
2015
446
0.050
 Why?
Gene Rearrangement
1
2022
76
0.040
 Why?
Microarray Analysis
2
2012
69
0.040
 Why?
Syndecan-1
1
2021
73
0.040
 Why?
Chromosome Mapping
2
2011
149
0.040
 Why?
Polymerase Chain Reaction
2
2013
458
0.040
 Why?
Biomarkers, Pharmacological
2
2011
26
0.040
 Why?
Cell Line
2
2015
1020
0.040
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
 Why?
Cell Movement
1
2022
271
0.040
 Why?
Alternative Splicing
1
2021
61
0.040
 Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.040
 Why?
Gene Expression
2
2013
618
0.040
 Why?
Phosphoproteins
1
2021
123
0.040
 Why?
Lymphoma, Follicular
1
2020
27
0.040
 Why?
Prospective Studies
2
2016
2433
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
12
0.040
 Why?
Recurrence
1
2021
680
0.040
 Why?
Maintenance Chemotherapy
1
2019
52
0.040
 Why?
Syndrome
1
2019
247
0.040
 Why?
Transcription Elongation, Genetic
1
2017
4
0.030
 Why?
Physical Chromosome Mapping
1
2017
7
0.030
 Why?
Genetic Drift
1
2017
3
0.030
 Why?
Gene Knockdown Techniques
1
2018
110
0.030
 Why?
Caspases
1
2018
101
0.030
 Why?
Genetic Loci
1
2017
46
0.030
 Why?
Unfolded Protein Response
1
2017
35
0.030
 Why?
Xenograft Model Antitumor Assays
1
2018
218
0.030
 Why?
Mitosis
1
2017
87
0.030
 Why?
Molecular Targeted Therapy
1
2018
135
0.030
 Why?
Genetic Association Studies
1
2017
124
0.030
 Why?
Genetic Structures
1
2016
1
0.030
 Why?
Comparative Genomic Hybridization
1
2016
37
0.030
 Why?
Risk
1
2017
315
0.030
 Why?
Virus Integration
1
2016
10
0.030
 Why?
Algorithms
1
2020
673
0.030
 Why?
Computational Biology
1
2018
209
0.030
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
43
0.030
 Why?
Nuclear Proteins
1
2017
247
0.030
 Why?
Immunosuppressive Agents
1
2017
248
0.030
 Why?
Flow Cytometry
1
2017
396
0.030
 Why?
Tumor Microenvironment
1
2017
257
0.030
 Why?
Antibodies, Monoclonal
1
2019
475
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
19
0.030
 Why?
MafB Transcription Factor
1
2015
9
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
 Why?
Cytidine Deaminase
1
2015
12
0.030
 Why?
RNA Stability
1
2015
29
0.030
 Why?
Amino Acid Sequence
1
2016
576
0.030
 Why?
Patient Selection
1
2016
269
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
18
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
53
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
12
0.030
 Why?
Cytogenetic Analysis
1
2014
79
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
 Why?
Time Factors
1
2021
2987
0.030
 Why?
Introns
1
2014
53
0.030
 Why?
Single-Cell Analysis
1
2014
71
0.030
 Why?
Methylation
1
2014
124
0.030
 Why?
Protein Isoforms
1
2014
127
0.030
 Why?
Base Sequence
1
2015
632
0.030
 Why?
Down-Regulation
1
2015
348
0.030
 Why?
High-Throughput Screening Assays
1
2013
39
0.030
 Why?
Molecular Sequence Data
1
2015
778
0.030
 Why?
Protein Structure, Tertiary
1
2014
260
0.030
 Why?
HeLa Cells
1
2014
243
0.030
 Why?
Osteonectin
1
2013
10
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
29
0.030
 Why?
Karyotyping
1
2013
77
0.030
 Why?
Azacitidine
1
2013
39
0.030
 Why?
Transforming Growth Factor beta1
1
2013
61
0.020
 Why?
Mass Spectrometry
1
2014
294
0.020
 Why?
Homologous Recombination
1
2013
44
0.020
 Why?
Disease Models, Animal
1
2018
1483
0.020
 Why?
Early Detection of Cancer
1
2014
185
0.020
 Why?
Apoptosis
1
2018
1120
0.020
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Tumor Suppressor Proteins
1
2013
127
0.020
 Why?
Gene Library
1
2012
42
0.020
 Why?
Laboratories
1
2012
19
0.020
 Why?
Hemizygote
1
2011
6
0.020
 Why?
Predictive Value of Tests
1
2014
938
0.020
 Why?
Animals
2
2018
13485
0.020
 Why?
Drug Resistance, Neoplasm
1
2013
336
0.020
 Why?
Breast Neoplasms
1
2020
1203
0.020
 Why?
Bone Marrow
1
2013
354
0.020
 Why?
Vincristine
1
2010
89
0.020
 Why?
Prednisolone
1
2010
56
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
412
0.020
 Why?
Cluster Analysis
1
2010
236
0.020
 Why?
Precancerous Conditions
1
2010
87
0.020
 Why?
Cyclophosphamide
1
2010
176
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
141
0.020
 Why?
Clinical Trials as Topic
1
2012
461
0.020
 Why?
Stem Cell Transplantation
1
2010
188
0.020
 Why?
Models, Biological
1
2012
735
0.020
 Why?
Sex Factors
1
2011
735
0.020
 Why?
Up-Regulation
1
2010
462
0.020
 Why?
Doxorubicin
1
2010
246
0.020
 Why?
Risk Assessment
1
2013
1349
0.020
 Why?
Prevalence
1
2011
1016
0.020
 Why?
Mice
1
2018
5899
0.020
 Why?
Young Adult
1
2015
4346
0.010
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (248) concept(s)
_
Co-Authors Expand Description
See all (29) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department